Tanzisertib
| CAS No. | 899805-25-5 | Cat. No. | BCP16541 |
| Name | Tanzisertib | ||
| Synonyms | CC 930;CC930;CC-930; | ||
| Formula | C21H23F3N6O2 | M. Wt | 448.44 |
| Description | Tanzisertib, also known as CC-930, is a potent, selective, and orally active JNK inhibitor with potential antifibrotic activity. CC-930 entered Phase I clinical trials. Tanzisertib may have potential use for prevention and treatment of dermal fibrosis. Selective inhibition of JNK by CC-930 exerted potent antifibrotic effects in vitro and in different models in vivo. JNK might thus be a novel molecular target for the treatment of fibrosis in SSc. | ||
| Pathways | MAPK Pathway | ||
| Targets | JNK | ||
Structure
Part data of this page collected from the open network resources, so Biochempartner can not guarantee its accuracy.
For product details of different batches, please contact our Customer
- Service & Tech Support:orders@biochempartner.com
- Website:www.biochempartner.com
Products are for research use only and not for human use. We do not sell to patients.